Clinical and experimental features of MuSK antibody positive MG in Japan

Authors: Ohta, K.1; Shigemoto, K.2; Fujinami, A.3; Maruyama, N.4; Konishi, T.5; Ohta, M.

Source: European Journal of Neurology, Volume 14, Number 9, September 2007 , pp. 1029-1034(6)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

We investigated the presence of antibodies (Abs) against muscle-specific tyrosine kinase (MuSK) in Japanese myasthenia gravis (MG) patients. MuSK Abs were found in 23 (27%) of 85 generalized seronegative MG (SNMG) patients but not in any of the ocular MG patients. MuSK Ab-positive patients were characterized as having female dominance (M:F, 5:18), age range at onset 18 to 72 (median 45) years old, and prominent oculobulbar symptoms (100%) with neck (57%) or respiratory (35%) muscle weakness. Limb muscle weakness was comparatively less severe (52%), thymoma absent. Most patients had good responses to simple plasma exchange and steroid therapy. MuSK IgG from all 18 patients was exclusively the IgG 4 subclass and bound mainly with the MuSK Ig 1-2 domain. Serial studies of 12 individuals showed a close correlation between the variation in MuSK Ab titers and MG clinical severity (P = 0.01 by Kruskal-Wallis). MuSK Ab titers were sharply decreased in patients who had a good response to early steroid therapy or simple plasma exchange, but there was no change, or a rapid increase on exacerbation after thymectomy. Measurement of MuSK Ab titers aids in the diagnosis of MG and the monitoring of clinical courses after treatment.

Keywords: clinical features; domain; IgG subclass; muscle specific tyrosine kinase; MuSK antibody; myasthenia gravis; seronegative myasthenia gravis

Document Type: Research article

DOI: 10.1111/j.1468-1331.2007.01870.x

Affiliations: 1: Clinical Research Center, Utano National Hospital, Kyoto, Japan 2: Department of Preventive Medicine, Faculty of Medicine, Graduate School of Ehime University, Ehime, Japan 3: Department of Medical Biochemistry, Kobe Pharmaceutical University, Kobe, Japan 4: Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan 5: Department of Neurology, Utano National Hospital, Kyoto, Japan

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A